Conversion surgery for initially unresectable hepatocellular carcinoma using lenvatinib combined with TACE plus PD-1 inhibitor: A real-world observational study
Titel:
Conversion surgery for initially unresectable hepatocellular carcinoma using lenvatinib combined with TACE plus PD-1 inhibitor: A real-world observational study
Auteur:
Li, Xingzhi Wang, Xiaobo Bai, Tao Chen, Jie Lu, Shaolong Wei, Tao Tang, Zhihong Zhao, Guilin Lu, Huaze Li, Lequn Wu, Feixiang